XML 49 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

Net (Loss) Income Per Share | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
Net (Loss) Income Per Share | 14. Net (Loss) Income Per Share The following table sets forth the computation of the basic and diluted net (loss) income per share (in thousands, except for share and per share data):
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Numerator, basic: |  |  |  |  |  |
Net (loss) income |  | $ | (71,798 | ) |  | $ | 4,180 |
Allocation of earnings to participating preferred stockholders |  |  | — |  |  |  | (3,613 | )
Net (loss) income applicable to common stockholders |  | $ | (71,798 | ) |  | $ | 567 |
Denominator, basic: |  |  |  |  |  |
Weighted-average shares outstanding used to compute net (loss) income per common share, basic |  |  | 9,891,126 |  |  |  | 1,928,586 |
Numerator, diluted: |  |  |  |  |  |
Net (loss) income |  | $ | (71,798 | ) |  | $ | 4,180 |
Allocation of earnings to participating preferred stockholders |  |  | — |  |  |  | (3,551 | )
Net (loss) income applicable to common stockholders |  | $ | (71,798 | ) |  | $ | 629 |
Denominator, diluted: |  |  |  |  |  |
Weighted-average shares outstanding used to compute net (loss) income per common share, basic |  |  | 9,891,126 |  |  |  | 1,928,586 |
Common stock options |  |  | — |  |  |  | 14,737 |
Unvested restricted stock |  |  | — |  |  |  | 233,801 |
Weighted-average shares outstanding used to compute net (loss) income per common share, diluted |  |  | 9,891,126 |  |  |  | 2,177,124 |
Net (loss) income per share, basic |  | $ | (7.26 | ) |  | $ | 0.29 |
Net (loss) income per share, diluted |  | $ | (7.26 | ) |  | $ | 0.29 |
Potentially dilutive securities not included in the calculation of diluted net (loss) income per share because to do so would be anti-dilutive were as follows (in common stock equivalent shares):
|  | As of December 31, |
|  | 2024 |  |  | 2023 |
Outstanding stock options |  |  | 2,938,982 |  |  |  | 198,084 |
Unvested restricted stock awards subject to repurchase |  |  | 576,829 |  |  |  | 340,649 |
Total antidilutive securities |  |  | 3,515,811 |  |  |  | 538,733 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration